379 related articles for article (PubMed ID: 16991035)
1. [ICD-implantation--for which patients is its value for primary prevention secure?].
Fiek M; Reithmann C; Steinbeck G
Dtsch Med Wochenschr; 2006 Sep; 131(39):2165-8. PubMed ID: 16991035
[No Abstract] [Full Text] [Related]
2. Who should receive the subcutaneous implanted defibrillator?: The subcutaneous implantable cardioverter defibrillator (ICD) should be considered in all ICD patients who do not require pacing.
Poole JE; Gold MR
Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1236-44; discussion 1244-5. PubMed ID: 24347599
[No Abstract] [Full Text] [Related]
3. Implantable cardioverter-defibrillators after myocardial infarction.
Myerburg RJ
N Engl J Med; 2008 Nov; 359(21):2245-53. PubMed ID: 19020326
[No Abstract] [Full Text] [Related]
4. Prophylactic implantable cardioverter defibrillator therapy in dilated cardiomyopathy: impact of left ventricular function.
Schaer BA; Ammann P; Sticherling C; Zellweger MJ; Cron TA; Osswald S
Int J Cardiol; 2006 Mar; 108(1):26-30. PubMed ID: 16516695
[TBL] [Abstract][Full Text] [Related]
5. [Usefulness of the implantable cardiodefibrillator (ICD) in the prevention of sudden death. Results of evidence based medicine].
González CM
Arch Cardiol Mex; 2007; 77 Suppl 2():S2-44-S2-46. PubMed ID: 17972377
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
[TBL] [Abstract][Full Text] [Related]
7. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
Das M
Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214
[TBL] [Abstract][Full Text] [Related]
8. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
Klein MH; Gold MR
Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188
[TBL] [Abstract][Full Text] [Related]
9. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
[TBL] [Abstract][Full Text] [Related]
10. AICD treatment in 2004--state of the art.
Budde T
Eur J Med Res; 2006 Oct; 11(10):432-8. PubMed ID: 17107877
[TBL] [Abstract][Full Text] [Related]
11. Proportion of patients followed in a specialized heart failure clinic needing an implantable cardioverter defibrillator as determined by applying different trial eligibility criteria.
Toma M; McAlister FA; Ezekowitz J; Kimber S; Gulamhusein S; Pantano A; Sivakumaran S; Cujec B; Paterson I; Armstrong PW
Am J Cardiol; 2006 Mar; 97(6):882-5. PubMed ID: 16516594
[TBL] [Abstract][Full Text] [Related]
12. The editor's roundtable: Implantable cardioverter-defibrillators in primary prevention of sudden cardiac death and disparity-related barriers to implementation.
Friedewald VE; Fonarow GC; Olshansky B; Yancy CW; Roberts WC
Am J Cardiol; 2011 Feb; 107(4):583-90. PubMed ID: 21295175
[No Abstract] [Full Text] [Related]
13. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
[TBL] [Abstract][Full Text] [Related]
14. [Primary prevention of sudden cardiac death].
Reek S; Geller JC; Klein HU
Dtsch Med Wochenschr; 2001 Apr; 126(15):435-8. PubMed ID: 11347006
[No Abstract] [Full Text] [Related]
15. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
Ding L; Hua W; Niu H; Chen K; Zhang S
Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F;
J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic implantable cardioverter-defibrillators after myocardial infarction--not for everyone.
Gillis AM
N Engl J Med; 2004 Dec; 351(24):2540-2. PubMed ID: 15590957
[No Abstract] [Full Text] [Related]
18. [Arrhythmia risk stratification based on etiological and anatomo-structural factors].
Disertori M; Dallafior D; Marini M
Ital Heart J Suppl; 2001 Dec; 2(12):1265-9. PubMed ID: 11838346
[TBL] [Abstract][Full Text] [Related]
19. [Idiopathic dilated cardiomyopathy--an appraisal in 2005].
Antz M; Bänsch D
Herz; 2005 Mar; 30(2):87-90. PubMed ID: 15875096
[TBL] [Abstract][Full Text] [Related]
20. Biventricular pacing and defibrillator use in chronic heart failure.
Cesario DA; Turner JW; Dec GW
Cardiol Clin; 2007 Nov; 25(4):595-603; vii. PubMed ID: 18063163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
